Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Tanezumab

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lilly, Pfizer stop study of arthritis drug after FDA rejection
    Lilly, Pfizer stop study of arthritis drug after FDA rejection

    27 Oct 2021

    // N.P. Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/lilly-pfizer-stop-development-osteoarthritis-drug-after-fda-rejection-extending-bleak-run

    N.P. Taylor FIERCEBIOTECH
    27 Oct 2021
    Share Share
    Lilly Reports Robust Third-Quarter 2021 Financial Results
    Lilly Reports Robust Third-Quarter 2021 Financial Results

    25 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-reports-robust-third-quarter-2021-financial-results-as-pipeline-success-strengthens-future-growth-potential-301408065.html

    PRNEWSWIRE
    25 Oct 2021
    Share Share
    Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer
    Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer

    23 Sep 2021

    // Nick Paul Taylor RAPS

    https://www.raps.org/news-and-articles/news-articles/2021/9/euro-roundup-chmp-recommends-drugs-from-biogen-and

    Nick Paul Taylor RAPS
    23 Sep 2021
    Share Share
    US FDA accepts regulatory submission of Pfizer & Eli Lilly's tanezumab
    US FDA accepts regulatory submission of Pfizer & Eli Lilly's tanezumab

    03 Mar 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=121575&sid=2

    PHARMABIZ
    03 Mar 2020
    Share Share
    U.S. FDA Accepts Regulatory Sub for Tanezumab, a Potential First-in-Class
    U.S. FDA Accepts Regulatory Sub for Tanezumab, a Potential First-in-Class

    02 Mar 2020

    // PRESS RELEASE

    https://investor.lilly.com/news-releases/news-release-details/us-fda-accepts-regulatory-submission-tanezumab-potential-first

    PRESS RELEASE
    02 Mar 2020
    Share Share
    Lilly Bio-Medicines chief Christi Shaw steps aside, leaving key launches behind
    Lilly Bio-Medicines chief Christi Shaw steps aside, leaving key launches behind

    11 Jul 2019

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amid-important-launches-lilly-s-bio-medicines-head-shaw-steps-aside

    Eric Sagonowsky FIERCE PHARMA
    11 Jul 2019
    Share Share